Assignee
APICORE US LLC
US·14 granted patents·12 pending applications·3 citations·filing 2014–2020
Top patents by PatentIndex Score
26 records- 0181US10626086B2Process for the preparation of isosulfan blueAPICORE US LLC·Filed 2019·Granted Apr 21, 2020·0 cites·13 claims
- 0280US10508080B2Process for the preparation of isosulfan blueAPICORE US LLC·Filed 2019·Granted Dec 17, 2019·0 cites·18 claims
- 0380US10464888B2Process for the preparation of isosulfan blueAPICORE US LLC·Filed 2019·Granted Nov 5, 2019·0 cites·22 claims
- 0479US10590071B2Process for the preparation of isosulfan blueAPICORE US LLC·Filed 2018·Granted Mar 17, 2020·0 cites·21 claims
- 0579US9493473B2Processes for making ponatinib and intermediates thereofAPICORE US LLC·Filed 2015·Granted Nov 15, 2016·2 cites·8 claims
- 0676US2020347013A1Process for preparation of isosulfan blueAPICORE US LLC·Filed 2020·Application pending·0 cites
- 0775US10752580B2Process for preparation of isosulfan blueAPICORE US LLC·Filed 2017·Granted Aug 25, 2020·0 cites·13 claims
- 0873US10221184B2Polymorphs of ponatinib hydrochlorideAPICORE US LLC·Filed 2018·Granted Mar 5, 2019·1 cites·12 claims
- 0970US2016221936A1Process for preparation of isosulfan blueAPICORE US LLC·Filed 2016·Application pending·0 cites
- 1062US11034714B2Process of making regadenoson and novel polymorphs thereofAPICORE US LLC·Filed 2019·Granted Jun 15, 2021·0 cites·10 claims
- 1158US9150511B2Process for preparing saxagliptin and its novel intermediates useful in the synthesis thereofAPICORE US LLC·Filed 2014·Granted Oct 6, 2015·0 cites·2 claims
- 1254US2017008848A1Methods of making netupitant and intermediates thereofAPICORE US LLC·Filed 2016·Application pending·0 cites
- 1351US10442832B2Process of making regadenoson and novel polymorph thereofAPICORE US LLC·Filed 2016·Granted Oct 15, 2019·0 cites·9 claims
- 1451US2015315149A1Methods of making netupitant and intermediates thereofAPICORE US LLC·Filed 2015·Application pending·0 cites
- 1550US10519121B2Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable saltsAPICORE US LLC·Filed 2017·Granted Dec 31, 2019·0 cites·4 claims
- 1649US9822145B2Methods of making carfilzomib and intermediates thereofAPICORE US LLC·Filed 2016·Granted Nov 21, 2017·0 cites·15 claims
- 1748US2014336369A1Process for preparing heparinoids and intermediates useful in the synthesis thereofAPICORE US LLC·Filed 2014·Application pending·0 cites
- 1847US9988389B2Processes for making ponatinib and intermediates thereofAPICORE US LLC·Filed 2016·Granted Jun 5, 2018·0 cites·7 claims
- 1947US2016368875A1Methods of making netupitant and intermediates thereofAPICORE US LLC·Filed 2016·Application pending·0 cites
- 2047US2018037606A1Methods of making carfilzomib and intermediates thereofAPICORE US LLC·Filed 2017·Application pending·0 cites
- 2146US10392417B2Polymorph of regadenoson and process for preparation thereofAPICORE US LLC·Filed 2017·Granted Aug 27, 2019·0 cites·4 claims
- 2246US2018044345A1Processes for making ponatinib and intermediates thereofAPICORE US LLC·Filed 2017·Application pending·0 cites
- 2343US2016115198A1Methods of making carfilzomib and intermediates thereofAPICORE US LLC·Filed 2015·Application pending·0 cites
- 2437US2018009825A1Methods of making eribulin mesylateAPICORE US LLC·Filed 2017·Application pending·0 cites
- 2535US2017260157A1Process for preparation and purification of pomalidomideAPICORE US LLC·Filed 2017·Application pending·0 cites
- 2633US2018009831A1Process for the preparation of novel polymorphic forms of 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaboroleAPICORE US LLC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →